INIS
antibodies
97%
patients
93%
receptors
83%
acetylcholine
53%
muscles
45%
antigens
41%
proteins
34%
diseases
33%
kinases
29%
rats
25%
surfaces
24%
encephalitis
23%
symptoms
21%
plasma cells
20%
brain
16%
control
15%
therapy
14%
humans
13%
monoclonal antibodies
13%
inhibition
11%
lipoproteins
11%
membranes
11%
levels
11%
junctions
10%
thymus
10%
ions
9%
transmission
9%
origin
9%
production
9%
cell cultures
8%
Keyphrases
Autoantibodies
87%
Myasthenia Gravis
85%
Acetylcholine Receptor (AChR)
58%
Musk
25%
Plasma Cells
19%
Neuropsychiatric Disorders
18%
Experimental Autoimmune Myasthenia Gravis
17%
Psychotic Disorders
17%
Autoimmune Disease
16%
IgG4-related Disease (IgG4-RD)
15%
Bortezomib
15%
Acetylcholine Receptor Antibody
14%
Neuromuscular Junction
11%
Ceramide
11%
Proteasome Inhibition
11%
Autoimmune Encephalitis
10%
Onconeural Antibodies
10%
Monoclonal Antibody
9%
Cell Culture
9%
Autoimmunity
9%
Complement Activation
9%
Encephalitis
8%
Thymus
8%
Neuromuscular Transmission
8%
B Cells
8%
Autoimmune
8%
Autoantigen
7%
Autoantibody Production
7%
Glutamic Acid Decarboxylase 65 (GAD65)
7%
Pathophysiology
7%
Immunology and Microbiology
Autoantibodies
100%
Myasthenia gravis
86%
Muscle
43%
Immunoglobulin Producing Cell
21%
B Cell
19%
Proteasome
17%
Experimental Autoimmune Myasthenia Gravis
17%
Immunoglobulin G4
16%
Monoclonal Antibody
14%
Autoimmune Disease
13%
Neuromuscular Junction
11%
Prevalence
10%
Autoimmunity
9%
Complement Activation
9%
Encephalitis
8%
Cell Culture
8%
Membrane Antigen
7%
Thymus
7%
Autoantigen
7%
Binding Antibody
7%
Neuromuscular Transmission
7%
Immunoglobulin G1
7%
Blood Plasma
7%
Tibialis Anterior Muscle
6%
Immunosuppression
6%
Binding Site
6%
Hippocampus
6%
Arm
6%
Postsynaptic Membrane
6%
Immunosuppressive Drug
6%